KRASG12C IN-16
KRASG12C IN-16 (Compound SK-17) is a selective, covalent and an orally active KRASG12C inhibitor. KRASG12C IN-16 induces Apoptosis. KRASG12C IN-16 effectively prevents the activation of MAPK and PI3K/mTOR signaling pathways. KRASG12C IN-16 displays anti-tumor activity against pancreatic cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C28H35ClN8O2
- Masse moléculaire:551.08
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
KRAS(G12C) |
Chemical Information
-
Masse moléculaire 551.08
-
Formule C28H35ClN8O2
-
SMILES
ClC1=C(C(NC(N2CC3=NC(N4CC(C4)N(C)C)=NC(N5C6CN(CC5CC6)C(C=C)=O)=C3C2)=O)=CC=C1)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KRASG12C IN-16 Related Classifications
HY-168919 Related Classifications
Powered by Bioz